ZUSAMMENSETZUNGEN UND VERWENDUNG VON TYROSINKINASE-HEMMERN ZUR BEHANDLUNG VON PATHOGENEN INFEKTIONEN

摘要

Compositions and methods are provided for using tyrosine kinase inhibitors to treat pathogenic infection. In particular, methods for using Abl-family tyrosine kinase inhibitors to treat pathogenic infection are provided. Infections to be treated according to the present invention include, particularly, those caused by microbial pathogens such as bacteria and viruses.